WuXi PharmaTech, China's premier provider of pharmaceutical R&D outsourcing services, has announced that its future GLP center in Suzhou started construction on September 29, 2007.
WuXi PharmaTech will build a 267,000 square foot state-of-the-art preclinical drug safety evaluation center situated in Wuzhong district, Suzhou, 60 kilometers from Shanghai.
The company said the center will provide customers with a broad range of highly value-added toxicology services. The company has already begun offering toxicology services at a smaller interim facility in Suzhou. The services to be provided at the new center will be more comprehensive and with much greater capacity.
The center is expected to become the largest modern drug safety evaluation center in China after its completion in 2009.
Founded in 2000, Shanghai-based WuXi PharmaTech is the leading China-based pharmaceutical and biotechnology R&D outsourcing company.